Healthcare -
Biotechnology - NASDAQ - US
$ 3.99
0.251 %
$ 258 M
Market Cap
-2.37
P/E
INZY - NET INCOME
Net Income INZY - Inozyme Pharma, Inc.
-102 M
LAST VALUE
-23.34%
2 YEAR CAGR
-38.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR